Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_08889 | 26 | 0.54 | Mlig455_054256 | Neo: - Age: - |
Mlig455_054256 {REF} {Length: 1360} {NoTransDecoderORF} {RNA1509_50721} {RNA1310_33163} {RNA815_21535} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.575 | 0.808 | 0.99937 | 1.00000 | |
RegionR2 | 1.664 | 0.808 | 1.00000 | 1.00000 | |
RegionR3 | -0.314 | 0.808 | 0.99914 | 1.00000 | |
RegionR4 | -1.637 | 0.808 | 1.00000 | 1.00000 | |
RegionR5 | -1.014 | 0.808 | 0.99924 | 1.00000 | |
RegionR6 | -0.222 | 0.808 | 0.99980 | 1.00000 | |
RegionR7 | 0.957 | 0.808 | 0.99980 | 1.00000 | |
RegionR8 | 1.142 | 0.808 | 0.99914 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 1.56 | 0.808 | 0.99930 | 1.00000 | |
RegenerationR2 | 3.269 | 0.808 | 0.07323 | 0.43911 | |
RegenerationR3 | 4.042 | 0.808 | 0.06811 | 0.43846 | |
RegenerationR4 | 2.737 | 0.808 | 0.09645 | 0.48205 | |
RegenerationR5 | 4.27 | 0.808 | 0.04770 | 0.35382 | |
RegenerationR6 | 3.625 | 0.808 | 0.09346 | 0.38013 | |
RegenerationBL | 7.029 | 0.808 | 0.00578 | 0.07229 | |
RegenerationTP | 4.459 | 0.808 | 0.11245 | 0.51515 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_08889 | 26 | 0.54 | Mlig455_054256 | Neo: - Age: - |
2 | - | - | - | - | 1.000 | 1.000 | Mlig455_054256 {REF} {Length: 1360} {NoTransDecoderORF} {RNA1509_50721} {RNA1310_33163} {RNA815_21535} | |
2. | MligTC455_16142 | 67 | 1.41 | Mlig455_028937 | Neo: - Age: - |
1.681 | - | - | - | - | 0.721 | 0.960 | Mlig455_028937 {REF} {Length: 2115} {NoTransDecoderORF} {RNA1509_53775} {RNA1310_26215.1, RNA1509_53775} {RNA1509_53775, RNA815_54266} | |
3. | MligTC455_46554 | 47 | 0.97 | Mlig455_038253 | Neo: - Age: logFC(26M/2M)=-0.562 |
0.985 | - | - | - | - | - | 0.985 | Mlig455_038253 {REF} {Length: 1890} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=60.6]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=94.4, Expect=7e-24]} {RNA1310_40614} {RNA815_32173} | |
4. | MligTC455_16032 | 77 | 1.61 | Mlig455_037337 | Neo: Irradiation |
0.984 | - | - | - | - | - | 0.984 | Mlig455_037337 {REF} {Length: 3079} {Pfam: Neuralized [PF07177.14, score=30.4]} {RNA1310_49372} | |
5. | MligTC455_31201 | 73 | 1.53 | Mlig455_045851, Mlig455_045867 | Neo: - Age: Up-Down-Up |
LRRC9 | 0.982 | - | - | - | - | - | 0.982 | Mlig455_045851 {REF} {Length: 5484} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.6]; Leucine rich repeat [PF13855.8, score=111.6]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=437, Expect=1e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=73.6, Expect=1e-12]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=7e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=368, Expect=4e-108]} {RNA1509_22179} {RNA1310_1731, RNA1509_22179} {RNA1509_22179, RNA815_589.1} Mlig455_045867 {REF} {Length: 5480} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.3]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.0]; Leucine rich repeat [PF13855.8, score=111.3]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=436, Expect=2e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=74.7, Expect=6e-13]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=8e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=369, Expect=2e-108]} {RNA1509_22179} {RNA1310_1731} {RNA815_589.1} |
6. | MligTC455_09301 | 26 | 0.55 | Mlig455_011440 | Neo: - Age: - Regeneration-upregulated BL: 7.313 Regeneration-enriched BL: 7.313 |
0.981 | - | - | - | - | - | 0.981 | Mlig455_011440 {REF} {Length: 331} {NoTransDecoderORF} {RNA1509_58496} {RNA1310_68696} {RNA815_38510} | |
7. | MligTC455_24711 | 46 | 0.96 | Mlig455_015705 | Neo: - Age: - Regeneration-upregulated BL: 6.967 Regeneration-enriched BL: 6.967 |
0.981 | - | - | - | - | - | 0.981 | Mlig455_015705 {REF} {Length: 1380} {NoTransDecoderORF} {RNA1509_40708} {RNA1310_77515} {RNA815_26884} | |
8. | MligTC455_53118 | 133 | 2.76 | Mlig455_029477 | Neo: - Age: - |
CHRNA2 | 0.979 | - | - | - | - | - | 0.979 | Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334} |
9. | MligTC455_02323 | 125 | 2.59 | Mlig455_042840 | Neo: - Age: - Region-enriched R7: 3.998/0.00319 |
HRASLS | 0.977 | - | - | - | - | - | 0.977 | Mlig455_042840 {REF} {Length: 1042} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=47.1]} {Human: ENSG00000127252, HRASLS, HRAS like suppressor, [Score=47.8, Expect=7e-06]} {Mouse: ENSMUSG00000028003, Lrat, lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase), [RH, Score=47.8, Expect=4e-06]} {RNA1310_85008} {RNA815_46214} |
10. | MligTC455_02324 | 121 | 2.51 | Mlig455_045874 | Neo: - Age: - Region-enriched R7: 4.211/0.00373 |
HRASLS | 0.977 | - | - | - | - | - | 0.977 | Mlig455_045874 {REF} {Length: 1080} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=47.1]} {Human: ENSG00000127252, HRASLS, HRAS like suppressor, [Score=47.8, Expect=7e-06]} {Mouse: ENSMUSG00000028003, Lrat, lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase), [RH, Score=47.4, Expect=5e-06]} {RNA1310_85008} {RNA815_46214} |
11. | MligTC455_10321 | 235 | 4.89 | Mlig455_004945, Mlig455_035629, Mlig455_055310 | Neo: - Age: - |
0.977 | - | - | - | - | - | 0.977 | Mlig455_004945 {REF} {Length: 80} {NoTransDecoderORF} {RNA1509_52583} {RNA1310_6592} {RNA815_13363} Mlig455_035629 {REF} {Length: 143} {NoTransDecoderORF} {RNA1509_52583} {RNA1310_6592} {RNA815_13363} Mlig455_055310 {REF} {Length: 2978} {RNA1509_52583} {RNA1310_43983.1} {RNA815_13363} |
|
12. | MligTC455_11926 | 101 | 2.11 | Mlig455_021319 | Neo: - Age: - Region-enriched R7: 4.905/0.00107 |
0.975 | - | - | - | - | - | 0.975 | Mlig455_021319 {REF} {Length: 2758} {Pfam: Mab-21 protein [PF03281.16, score=23.9]} {RNA1509_41055} {RNA1310_11481.1} {RNA815_44675} | |
13. | MligTC455_17524 | 186 | 3.87 | Mlig455_019598 | Neo: - Age: - |
0.974 | - | - | - | - | - | 0.974 | Mlig455_019598 {REF} {Length: 2178} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=88.0]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=50.1, Expect=3e-06]} {Smed: dd_Smed_v6_15195_0_1, dd_Smed_v6_15195_0_1, [Score=56.2, Expect=2e-08]} {RNA1509_35331} {RNA1310_2795.1} {RNA815_4169} | |
14. | MligTC455_18401 | 44 | 0.92 | Mlig455_060625 | Neo: - Age: - |
0.974 | - | - | - | - | - | 0.974 | Mlig455_060625 {REF} {Length: 2190} {NoTransDecoderORF} {RNA1509_38113} {RNA1310_33283} {RNA815_55541} | |
15. | MligTC455_16176 | 76 | 1.58 | Mlig455_048486 | Neo: Int S/G2/M Age: - |
GCM1 | 0.973 | - | - | - | - | - | 0.973 | Mlig455_048486 {REF} {Length: 2372} {Pfam: GCM motif protein [PF03615.17, score=223.0]} {Human: ENSG00000137270, GCM1, glial cells missing homolog 1, [RH, Score=197, Expect=3e-57]; ENSG00000124827, GCM2, glial cells missing homolog 2, [RH, Score=191, Expect=2e-54]} {Mouse: ENSMUSG00000023333, Gcm1, glial cells missing homolog 1, [RH, Score=192, Expect=1e-55]; ENSMUSG00000021362, Gcm2, glial cells missing homolog 2, [RH, Score=189, Expect=1e-53]} {Dmel: FBgn0014179, gcm, glial cells missing, [RH, Score=230, Expect=2e-69]} {Smed: dd_Smed_v6_15107_0_1, dd_Smed_v6_15107_0_1, [RH, Score=186, Expect=3e-54]} {RNA1509_58813} {RNA1310_66943} {RNA815_43872} |
16. | MligTC455_21582 | 28 | 0.58 | Mlig455_048795 | Neo: - Age: - |
0.973 | - | - | - | - | - | 0.973 | Mlig455_048795 {REF} {Length: 582} {NoTransDecoderORF} | |
17. | MligTC455_26668 | 406 | 8.46 | Mlig455_011365 | Neo: - Age: - Regeneration-upregulated BL: 6.270 Regeneration-enriched BL: 6.270 |
0.973 | - | - | - | - | - | 0.973 | Mlig455_011365 {REF} {Length: 3699} {Pfam: Protein of unknown function (DUF1104) [PF06518.13, score=20.7]} {RNA1509_40399} {RNA1310_340.1} {RNA815_1857} | |
18. | MligTC455_06484 | 46 | 0.96 | Mlig455_061537 | Neo: - Age: - |
0.972 | - | - | - | - | - | 0.972 | Mlig455_061537 {REF} {Length: 542} {NoTransDecoderORF} {RNA1310_116180} | |
19. | MligTC455_49527 | 147 | 3.06 | Mlig455_027843 | Neo: - Age: - |
0.972 | - | - | - | - | - | 0.972 | Mlig455_027843 {REF} {Length: 1796} {RNA1509_15103} {RNA1310_101911} {RNA815_59080} | |
20. | MligTC455_07085 | 16 | 0.34 | Mlig455_036968 | Neo: - Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_036968 {REF} {Length: 1519} {NoTransDecoderORF} {RNA1509_40555} {RNA1310_119499} {RNA815_47994} | |
21. | MligTC455_29737 | 119 | 2.48 | Mlig455_049700, Mlig455_049706, Mlig455_070465 | Neo: - Age: - Region-enriched R4: 5.563/0.03218 |
0.971 | - | - | - | - | - | 0.971 | Mlig455_049700 {REF} {Length: 1135} {NoTransDecoderORF} {RNA1509_57671} {RNA1310_18142} {RNA815_55954} Mlig455_049706 {REF} {Length: 1000} {NoTransDecoderORF} {RNA1509_34937} {RNA1310_18142} {RNA815_55954} Mlig455_070465 {REF} {Length: 884} {NoTransDecoderORF} {RNA1509_34937} {RNA1310_18142} {RNA815_55954} |
|
22. | MligTC455_18991 | 10967 | 228.47 | Mlig455_037440, Mlig455_037464, Mlig455_037503 | Neo: - Age: logFC(26M/2M)=-0.211 Regeneration-upregulated BL: 1.902 Regeneration-enriched BL: 1.902 |
CHRNA6 | 0.97 | - | - | - | - | - | 0.970 | Mlig455_037440 {REF} {Length: 2692} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=70.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=47.1]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=117, Expect=2e-28]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=112, Expect=5e-27]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=108, Expect=4e-25]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=108, Expect=2e-25]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=112, Expect=1e-26]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=110, Expect=3e-26]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=113, Expect=2e-27]} {RNA1509_24940, RNA1509_3092} {RNA1310_30196.2, RNA1509_24940} {RNA1509_24940, RNA815_25568} Mlig455_037464 {REF} {Length: 2686} {RNA1509_3092} {RNA1310_30196.2} {RNA815_6516} Mlig455_037503 {REF} {Length: 1172} {RNA1509_3092} {RNA1310_28554} {RNA815_6516} |
23. | MligTC455_20478 | 52 | 1.08 | Mlig455_031423 | Neo: - Age: - |
0.969 | - | - | - | - | - | 0.969 | Mlig455_031423 {REF} {Length: 1562} {NoTransDecoderORF} {RNA1310_4910} | |
24. | MligTC455_45063 | 105 | 2.19 | Mlig455_045829, Mlig455_045845, Mlig455_045862 | Neo: - Age: - |
0.968 | - | - | - | - | - | 0.968 | Mlig455_045829 {REF} {Length: 4186} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045845 {REF} {Length: 3433} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.9]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=101, Expect=1e-22]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045862 {REF} {Length: 3524} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1, RNA1509_43949} {RNA1509_43949, RNA815_26865} |
|
25. | MligTC455_11444 | 25 | 0.53 | Mlig455_066854 | Neo: - Age: - |
0.966 | - | - | - | - | - | 0.966 | Mlig455_066854 {REF} {Length: 845} {NoTransDecoderORF} {RNA1310_141915} | |
26. | MligTC455_14677 | 21 | 0.44 | Mlig455_004558, Mlig455_064752 | Neo: - Age: - |
TRPM2 | 0.966 | - | - | - | - | - | 0.966 | Mlig455_004558 {REF} {Length: 1754} {Pfam: SLOG in TRPM [PF18139.3, score=98.9]; Ankyrin repeats (3 copies) [PF12796.9, score=36.5]; Ankyrin repeat [PF13606.8, score=23.8]; Ankyrin repeat [PF00023.32, score=22.8]; Ankyrin repeats (many copies) [PF13857.8, score=20.3]; Ankyrin repeats (many copies) [PF13637.8, score=20.1]} {Human: ENSG00000142185, TRPM2, transient receptor potential cation channel subfamily M member 2, [Score=134, Expect=1e-32]} {Mouse: ENSMUSG00000009292, Trpm2, transient receptor potential cation channel, subfamily M, member 2, [Score=126, Expect=4e-30]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=82.0, Expect=5e-16]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_17981_0_3, dd_Smed_v6_17981_0_3, [Score=157, Expect=3e-41]} {RNA1310_103417} Mlig455_064752 {REF} {Length: 2527} {Pfam: SLOG in TRPM [PF18139.3, score=98.9]; Ankyrin repeats (3 copies) [PF12796.9, score=37.5]; Ankyrin repeat [PF13606.8, score=26.1]; Ankyrin repeats (many copies) [PF13637.8, score=25.3]; Ankyrin repeats (many copies) [PF13857.8, score=24.8]; Ankyrin repeat [PF00023.32, score=23.9]} {Human: ENSG00000142185, TRPM2, transient receptor potential cation channel subfamily M member 2, [Score=135, Expect=5e-33]} {Mouse: ENSMUSG00000009292, Trpm2, transient receptor potential cation channel, subfamily M, member 2, [Score=128, Expect=1e-30]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=82.4, Expect=5e-16]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=96.3, Expect=2e-20]} {Smed: dd_Smed_v6_17981_0_3, dd_Smed_v6_17981_0_3, [Score=157, Expect=4e-41]} {RNA1509_36146} {RNA1310_103417} {RNA815_131.5} |
27. | MligTC455_25287 | 78 | 1.62 | Mlig455_016988, Mlig455_021241, Mlig455_069255 | Neo: - |
FCN2 | 0.966 | - | - | - | - | - | 0.966 | Mlig455_016988 {REF} {Length: 1045} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=147.6]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=141, Expect=1e-39]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=134, Expect=1e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=134, Expect=8e-36]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [RH, Score=133, Expect=1e-36]} {Dmel: FBgn0030163, CG1791, [RH, Score=120, Expect=9e-32]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=105, Expect=2e-25]} {RNA1310_48119} {RNA815_52558} Mlig455_021241 {REF} {Length: 1723} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=97.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=104, Expect=2e-24]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=100, Expect=4e-22]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=102, Expect=8e-24]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=101, Expect=1e-22]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=99.0, Expect=5e-22]; ENSMUSG00000026841, Fibcd1, fibrinogen C domain containing 1, [Score=97.1, Expect=2e-21]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=97.1, Expect=3e-21]} {Dmel: FBgn0030163, CG1791, [Score=97.4, Expect=4e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.6, Expect=1e-18]} {RNA1509_12256} {RNA1310_326} {RNA815_351.1} Mlig455_069255 {REF} {Length: 8909} {RNA1509_33647, RNA1509_36216} {RNA1310_15325.1, RNA1509_33647, RNA1509_36216} {RNA1509_33647, RNA1509_36216, RNA815_10965} |
28. | MligTC455_50390 | 19 | 0.4 | Mlig455_016912 | Neo: - Age: - |
CHRNA3 | 0.966 | - | - | - | - | - | 0.966 | Mlig455_016912 {REF} {Length: 2944} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=242.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=157.8]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=326, Expect=7e-105]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=317, Expect=2e-101]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=317, Expect=2e-101]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=313, Expect=5e-100]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=320, Expect=8e-103]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=317, Expect=1e-101]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=315, Expect=2e-101]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=304, Expect=8e-97]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=347, Expect=1e-112]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [RH, Score=307, Expect=1e-98]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [RH, Score=539, Expect=0.0]} {RNA1310_33221} {RNA815_23594.2} |
29. | MligTC455_28130 | 73 | 1.52 | Mlig455_017884 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_017884 {REF} {Length: 3157} {NoTransDecoderORF} {RNA1509_13222} {RNA1310_34828.2} {RNA815_11419.1} | |
30. | MligTC455_42187 | 34 | 0.71 | Mlig455_026803 | Neo: - Age: Down-Up-Down |
0.965 | - | - | - | - | 0.965 | - | Mlig455_026803 {REF} {Length: 1654} {TRANSSPLICED} {RNA1509_29113} {RNA1310_18892.2} {RNA815_7576} | |
31. | MligTC455_50666 | 131 | 2.72 | Mlig455_034548 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_034548 {REF} {Length: 2489} {RNA1310_46048} {RNA815_41927} | |
32. | MligTC455_14502 | 32 | 0.67 | Mlig455_047308 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_047308 {REF} {Length: 1018} {TRANSSPLICED} {RNA1509_56030} {RNA1310_23619} {RNA815_11671} | |
33. | MligTC455_18799 | 47 | 0.98 | Mlig455_031256, Mlig455_031302 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_031256 {REF} {Length: 1098} Mlig455_031302 {REF} {Length: 1102} |
|
34. | MligTC455_28655 | 49 | 1.03 | Mlig455_048319 | Neo: - |
RNF213 | 0.963 | - | - | - | - | - | 0.963 | Mlig455_048319 {REF} {Length: 12875} {Pfam: ATPase family associated with various cellular activities (AAA) [PF00004.31, score=25.3]; AAA domain (dynein-related subfamily) [PF07728.16, score=23.1]} {Human: ENSG00000173821, RNF213, ring finger protein 213, [Score=329, Expect=5e-89]} {Mouse: ENSMUSG00000070327, Rnf213, ring finger protein 213, [Score=319, Expect=3e-86]} {RNA1509_30363} {RNA1310_550} {RNA815_15} |
35. | MligTC455_32436 | 43 | 0.91 | Mlig455_025074 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_025074 {REF} {Length: 2851} {RNA1509_1845} {RNA1310_50.1} {RNA815_5933} | |
36. | MligTC455_34192 | 134 | 2.8 | Mlig455_022589 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_022589 {REF} {Length: 1896} {RNA1509_34101} {RNA1310_46799} {RNA815_22648} | |
37. | MligTC455_40913 | 85 | 1.77 | Mlig455_067935 | Neo: - Age: - Regeneration-upregulated BL: 9.167 Regeneration-enriched BL: 9.167 |
ASCL5 | 0.963 | - | - | - | - | - | 0.963 | Mlig455_067935 {REF} {Length: 1417} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=44.2]} {Human: ENSG00000232237, ASCL5, achaete-scute family bHLH transcription factor 5, [Score=48.1, Expect=4e-06]; ENSG00000176009, ASCL3, achaete-scute family bHLH transcription factor 3, [Score=47.0, Expect=7e-06]} {Mouse: ENSMUSG00000097918, Ascl5, achaete-scute family bHLH transcription factor 5, [Score=48.5, Expect=2e-06]} {Dmel: FBgn0004170, sc, scute, [Score=55.1, Expect=2e-08]} {Celegans: WBGene00001950, hlh-3, Helix-loop-helix protein 3, [Score=47.0, Expect=3e-06]} |
38. | MligTC455_42682 | 45 | 0.93 | Mlig455_010400 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_010400 {REF} {Length: 1751} {NoTransDecoderORF} {RNA1509_58929} {RNA1310_128448} {RNA815_10390} | |
39. | MligTC455_42723 | 666 | 13.88 | Mlig455_069654 | Neo: Irradiation Age: - Region-enriched R7: 2.955/0.00360 Regeneration-upregulated BL: 3.069 Regeneration-enriched BL: 3.069 |
0.963 | - | - | - | - | - | 0.963 | Mlig455_069654 {REF} {Length: 1471} {RNA1310_30663.1} {RNA815_50207} | |
40. | MligTC455_10259 | 124 | 2.58 | Mlig455_052843 | Neo: Int S/G2/M Age: - |
0.962 | - | - | - | - | - | 0.962 | Mlig455_052843 {REF} {Length: 1170} {RNA1310_32241.1} {RNA815_32339} | |
41. | MligTC455_23808 | 31 | 0.65 | Mlig455_059306 | Neo: - Age: Down-Down-Up |
0.962 | - | - | - | - | - | 0.962 | Mlig455_059306 {REF} {Length: 1845} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=30.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042} | |
42. | MligTC455_29145 | 72 | 1.51 | Mlig455_014865 | Neo: - Age: - |
0.962 | - | - | - | - | - | 0.962 | Mlig455_014865 {REF} {Length: 3483} {RNA1509_13072} {RNA1310_989.1} {RNA815_1327.1} | |
43. | MligTC455_11316 | 16 | 0.32 | Mlig455_015383 | Neo: - Age: - |
0.96 | - | - | - | - | - | 0.960 | Mlig455_015383 {REF} {Length: 775} {TRANSSPLICED} {RNA1509_14043} {RNA1310_81640} {RNA815_13324.1} | |
44. | MligTC455_16657 | 842 | 17.53 | Mlig455_042515 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.634 Region-enriched R7: 2.586/0.00000 Regeneration-upregulated BL: 2.469 Regeneration-enriched BL: 2.469 |
FERD3L | 0.959 | - | - | - | - | - | 0.959 | Mlig455_042515 {REF} {Length: 1703} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=59.2]} {Human: ENSG00000146618, FERD3L, Fer3 like bHLH transcription factor, [RH, Score=111, Expect=4e-29]} {Mouse: ENSMUSG00000046518, Ferd3l, Fer3 like bHLH transcription factor, [RH, Score=111, Expect=3e-29]} {Dmel: FBgn0037937, Fer3, 48 related 3, [RH, Score=119, Expect=5e-32]} {Celegans: WBGene00001957, hlh-13, Helix-loop-helix protein 13, [Score=67.8, Expect=1e-13]} {Smed: dd_Smed_v6_8096_0_1, dd_Smed_v6_8096_0_1, [RH, Score=120, Expect=2e-32]} {RNA1509_28158} {RNA1310_23170} {RNA815_15242} |
45. | MligTC455_08216 | 34 | 0.7 | Mlig455_009138 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_009138 {REF} {Length: 379} {NoTransDecoderORF} {RNA1310_66482.1} {RNA815_62564} | |
46. | MligTC455_25309 | 27 | 0.56 | Mlig455_007405 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_007405 {REF} {Length: 5652} {RNA1509_20101} {RNA1310_66411} {RNA815_42952} | |
47. | MligTC455_28129 | 100 | 2.08 | Mlig455_006881 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_006881 {REF} {Length: 3777} {NoTransDecoderORF} {RNA1509_13222} {RNA1310_34828.2} {RNA815_11419.1} | |
48. | MligTC455_55434 | 12 | 0.24 | Mlig455_027850 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_027850 {REF} {Length: 485} {Pfam: Protein of unknown function (DUF3421) [PF11901.10, score=116.0]} {Dmel: FBgn0034583, CG10527, [Score=97.8, Expect=5e-25]} {Smed: dd_Smed_v6_87_0_2, dd_Smed_v6_87_0_2, [Score=129, Expect=6e-39]} {RNA1509_43784} {RNA1310_37041.1} {RNA815_16844.2} | |
49. | MligTC455_01195 | 22 | 0.47 | Mlig455_036133 | Neo: - Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_036133 {REF} {Length: 295} {NoTransDecoderORF} {RNA1509_56822} {RNA1310_22534} {RNA815_1171.1} | |
50. | MligTC455_47787 | 741 | 15.44 | Mlig455_059451 | Neo: - Age: logFC(26M/2M)=-0.505 Region-enriched R8: 1.658/0.04622 |
0.957 | - | - | - | - | - | 0.957 | Mlig455_059451 {REF} {Length: 2112} {RNA1509_40006} {RNA1310_14082, RNA1509_40006} {RNA1509_40006, RNA815_12176} | |
51. | MligTC455_48225 | 63 | 1.31 | Mlig455_056723, Mlig455_060295 | Neo: - Age: - |
GLRA3 | 0.956 | - | - | - | - | - | 0.956 | Mlig455_056723 {REF} {Length: 2758} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=129.4]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=270, Expect=2e-84]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=265, Expect=1e-82]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=264, Expect=3e-82]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=258, Expect=3e-80]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=265, Expect=7e-83]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=263, Expect=4e-82]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=263, Expect=6e-82]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=257, Expect=1e-79]; ENSMUSG00000033676, Gabrb3, gamma-aminobutyric acid (GABA) A receptor, subunit beta 3, [Score=255, Expect=9e-79]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=253, Expect=9e-78]} {Dmel: FBgn0024963, GluClalpha, [Score=254, Expect=1e-78]} {Celegans: WBGene00001593, glc-3, Glutamate-gated ChLoride channel; Glutamate-gated chloride channel subunit, [RH, Score=255, Expect=4e-79]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=224, Expect=4e-67]} {RNA1310_13574.1} {RNA815_10577.1} Mlig455_060295 {REF} {Length: 2660} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=129.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=95.7]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=240, Expect=4e-73]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=235, Expect=3e-71]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=233, Expect=8e-71]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=234, Expect=4e-71]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=233, Expect=2e-70]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=233, Expect=5e-71]; ENSMUSG00000033676, Gabrb3, gamma-aminobutyric acid (GABA) A receptor, subunit beta 3, [Score=226, Expect=7e-68]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=225, Expect=7e-68]} {Dmel: FBgn0024963, GluClalpha, [Score=215, Expect=4e-64]} {Celegans: WBGene00001593, glc-3, Glutamate-gated ChLoride channel; Glutamate-gated chloride channel subunit, [Score=222, Expect=2e-66]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=188, Expect=4e-54]} {RNA1310_13574.1} {RNA815_10577.1} |
52. | MligTC455_51246 | 58 | 1.2 | Mlig455_014016 | Neo: - Age: - |
0.956 | - | - | - | - | - | 0.956 | Mlig455_014016 {REF} {Length: 2834} {NoTransDecoderORF} {RNA1509_57004} {RNA1310_22299} {RNA815_15623} | |
53. | MligTC455_19124 | 68 | 1.41 | Mlig455_056714 | Neo: - Age: Up-Down-Up |
NPFFR1 | 0.955 | - | - | - | - | - | 0.955 | Mlig455_056714 {REF} {Length: 3702} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=113.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=90.1, Expect=1e-18]; ENSG00000137252, HCRTR2, hypocretin receptor 2, [Score=87.8, Expect=6e-18]} {Mouse: ENSMUSG00000038071, Npy6r, neuropeptide Y receptor Y6, [Score=105, Expect=2e-24]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=131, Expect=7e-33]} {Celegans: WBGene00003808, npr-2, NeuroPeptide Receptor family, [Score=100, Expect=1e-22]} {Smed: dd_Smed_v6_26109_0_1, dd_Smed_v6_26109_0_1, [RH, Score=210, Expect=4e-61]} {RNA1509_34547} {RNA1310_9062, RNA1509_34547} {RNA1509_34547, RNA815_6805} |
54. | MligTC455_20228 | 160 | 3.33 | Mlig455_025853, Mlig455_025915 | Neo: Irradiation Age: - Region-enriched R5: 2.361/0.00341 |
BLM | 0.955 | - | - | - | - | 0.955 | - | Mlig455_025853 {REF} {Length: 4872} {TRANSSPLICED} {Pfam: DEAD/DEAH box helicase [PF00270.31, score=68.7]; Helicase conserved C-terminal domain [PF00271.33, score=64.4]; RecQ zinc-binding [PF16124.7, score=57.3]; HRDC domain [PF00570.25, score=42.5]; RQC domain [PF09382.12, score=39.4]; Type III restriction enzyme, res subunit [PF04851.17, score=26.0]} {Human: ENSG00000197299, BLM, Bloom syndrome RecQ like helicase, [RH, Score=560, Expect=6e-176]} {Mouse: ENSMUSG00000030528, Blm, Bloom syndrome, RecQ like helicase, [RH, Score=555, Expect=5e-174]} {Dmel: FBgn0002906, Blm, Bloom syndrome helicase, [RH, Score=568, Expect=1e-178]} {Celegans: WBGene00001865, him-6, Bloom syndrome protein homolog, [RH, Score=484, Expect=5e-152]} {Smed: dd_Smed_v6_10119_0_1, dd_Smed_v6_10119_0_1, [RH, Score=662, Expect=0.0]} {RNA1509_10459} {RNA1310_1433} {RNA815_5612} Mlig455_025915 {REF} {Length: 4878} {TRANSSPLICED} {Pfam: DEAD/DEAH box helicase [PF00270.31, score=68.6]; Helicase conserved C-terminal domain [PF00271.33, score=64.2]; RecQ zinc-binding [PF16124.7, score=57.2]; HRDC domain [PF00570.25, score=42.4]; RQC domain [PF09382.12, score=39.3]; Type III restriction enzyme, res subunit [PF04851.17, score=25.9]} {Human: ENSG00000197299, BLM, Bloom syndrome RecQ like helicase, [RH, Score=558, Expect=1e-174]} {Mouse: ENSMUSG00000030528, Blm, Bloom syndrome, RecQ like helicase, [RH, Score=553, Expect=2e-172]} {Dmel: FBgn0002906, Blm, Bloom syndrome helicase, [RH, Score=567, Expect=2e-177]} {Celegans: WBGene00001865, him-6, Bloom syndrome protein homolog, [RH, Score=483, Expect=3e-151]} {Smed: dd_Smed_v6_10119_0_1, dd_Smed_v6_10119_0_1, [RH, Score=661, Expect=0.0]} {RNA1509_10459} {RNA1310_1433} {RNA815_5612} |
55. | MligTC455_21390 | 470 | 9.8 | Mlig455_013297, Mlig455_050507 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_013297 {REF} {Length: 1363} {TRANSSPLICED} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.6]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=129, Expect=2e-34]} {RNA1509_33360} {RNA1310_24109.1} {RNA815_9543} Mlig455_050507 {REF} {Length: 1891} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.6]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=129, Expect=1e-34]} {RNA1509_33360} {RNA1310_24109.3} {RNA815_9543} |
|
56. | MligTC455_26645 | 132 | 2.74 | Mlig455_032393, Mlig455_032437 | Neo: - Age: - |
B4GALT1 | 0.954 | - | - | - | - | - | 0.954 | Mlig455_032393 {REF} {Length: 2140} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=128.2]; N-terminal domain of galactosyltransferase [PF02709.16, score=66.3]} {Human: ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=178, Expect=1e-51]} {Mouse: ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=174, Expect=4e-50]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=149, Expect=6e-41]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=166, Expect=2e-47]} {Smed: dd_Smed_v6_12436_0_1, dd_Smed_v6_12436_0_1, [Score=174, Expect=7e-51]} {RNA1310_17913} {RNA815_20156} Mlig455_032437 {REF} {Length: 2249} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=126.3]; N-terminal domain of galactosyltransferase [PF02709.16, score=66.3]} {Human: ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=181, Expect=9e-53]} {Mouse: ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=176, Expect=5e-51]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=149, Expect=6e-41]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=166, Expect=2e-47]} {Smed: dd_Smed_v6_12436_0_1, dd_Smed_v6_12436_0_1, [Score=172, Expect=3e-50]} {RNA1310_17913} {RNA815_20156} |
57. | MligTC455_36185 | 71 | 1.48 | Mlig455_035985 | Neo: - Age: - |
KCNH7 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_035985 {REF} {Length: 3355} {Pfam: Ion transport protein [PF00520.33, score=118.6]; Ion channel [PF07885.18, score=46.2]; PAS domain [PF13426.9, score=44.5]; Cyclic nucleotide-binding domain [PF00027.31, score=43.8]; PAS fold [PF00989.27, score=22.5]; PAS fold [PF08447.14, score=21.9]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=795, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=786, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=773, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=795, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=794, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=774, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=714, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=775, Expect=0.0]} {RNA1509_16542} {RNA1310_5129.1} {RNA815_4089.1} |
58. | MligTC455_39057 | 57 | 1.18 | Mlig455_013966 | Neo: Int S/G2/M Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_013966 {REF} {Length: 1262} {NoTransDecoderORF} {RNA1310_104321} | |
59. | MligTC455_42325 | 270 | 5.62 | Mlig455_016673 | Neo: - Age: Down-Up-Up Region-enriched R7: 4.030/0.00009 |
EVX1 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_016673 {REF} {Length: 1449} {Pfam: Homeodomain [PF00046.31, score=74.8]} {Human: ENSG00000106038, EVX1, even-skipped homeobox 1, [RH, Score=131, Expect=1e-34]; ENSG00000174279, EVX2, even-skipped homeobox 2, [RH, Score=130, Expect=7e-34]} {Mouse: ENSMUSG00000005503, Evx1, even-skipped homeobox 1, [RH, Score=131, Expect=1e-34]; ENSMUSG00000001815, Evx2, even-skipped homeobox 2, [RH, Score=131, Expect=3e-34]} {Dmel: FBgn0000606, eve, even skipped, [RH, Score=136, Expect=4e-37]} {Celegans: WBGene00006873, vab-7, Homeobox protein vab-7, [RH, Score=110, Expect=3e-28]} {Smed: dd_Smed_v6_18147_0_1, dd_Smed_v6_18147_0_1, [RH, Score=117, Expect=2e-32]} {RNA1509_36832} {RNA1310_42544, RNA1509_36832} {RNA1509_36832, RNA815_33148} |
60. | MligTC455_00419 | 109 | 2.27 | Mlig455_003934 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_003934 {REF} {Length: 780} {NoTransDecoderORF} {RNA1509_46406} {RNA1310_72097} {RNA815_61152.1} | |
61. | MligTC455_14961 | 39 | 0.82 | Mlig455_048867 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_048867 {REF} {Length: 979} {NoTransDecoderORF} {RNA1310_98124} | |
62. | MligTC455_30270 | 406 | 8.46 | Mlig455_012719, Mlig455_044289 | Neo: Int S/G2/M Age: - Regeneration-upregulated BL: 4.823 Regeneration-enriched BL: 4.823 |
0.952 | - | - | - | - | - | 0.952 | Mlig455_012719 {REF} {Length: 392} {RNA1509_16349} {RNA1310_2575} Mlig455_044289 {REF} {Length: 4784} {RNA1509_16349} {RNA1310_2575} {RNA815_3500.1} |
|
63. | MligTC455_36587 | 498 | 10.38 | Mlig455_008305, Mlig455_008336, Mlig455_018336 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_008305 {REF} {Length: 5825} {RNA1509_27896} {RNA1310_7707.1, RNA1509_27896} {RNA1509_27896, RNA815_16784} Mlig455_008336 {REF} {Length: 4327} {RNA1509_40323} {RNA1310_7961.1, RNA1509_40323} {RNA1509_40323, RNA815_19771.1} Mlig455_018336 {REF} {Length: 5429} {RNA1509_40323} {RNA1310_22730} {RNA815_9953} |
|
64. | MligTC455_43912 | 108 | 2.26 | Mlig455_038979 | Neo: - Age: - Region-enriched R8: 3.794/0.00970 |
SNAI2 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_038979 {REF} {Length: 2442} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=89.3]; C2H2-type zinc finger [PF13894.8, score=57.9]; Zinc-finger double domain [PF13465.8, score=53.2]; Zinc-finger of C2H2 type [PF12874.9, score=40.2]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=40.0]; C2H2-type zinc finger [PF13912.8, score=35.8]; C2HE / C2H2 / C2HC zinc-binding finger [PF16278.7, score=24.6]; Zinc ribbon domain [PF09723.12, score=19.4]} {Human: ENSG00000019549, SNAI2, snail family transcriptional repressor 2, [RH, Score=204, Expect=3e-62]} {Mouse: ENSMUSG00000022676, Snai2, snail family zinc finger 2, [RH, Score=202, Expect=6e-62]} {Dmel: FBgn0001983, wor, worniu, [RH, Score=207, Expect=7e-61]} {Celegans: WBGene00019299, snai-1, SNAIl family zinc finger 2 transcription factor homolog, [Score=152, Expect=9e-44]} {Smed: dd_Smed_v6_10216_0_1, dd_Smed_v6_10216_0_1, [RH, Score=204, Expect=3e-62]} {RNA1509_43471} {RNA1310_64158} {RNA815_60731} |
65. | MligTC455_12390 | 239 | 4.98 | Mlig455_033352, Mlig455_033374 | Neo: - Age: - Region-enriched R8: 4.186/0.00002 |
SLC16A14 | 0.951 | - | - | - | - | - | 0.951 | Mlig455_033352 {REF} {Length: 3261} {Pfam: Major Facilitator Superfamily [PF07690.18, score=118.6]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=47.1]; Sugar (and other) transporter [PF00083.26, score=25.8]; MFS_1 like family [PF12832.9, score=20.5]; Type II CAAX prenyl endopeptidase Rce1-like [PF02517.18, score=19.9]; Vacuole effluxer Atg22 like [PF11700.10, score=19.2]} {Human: ENSG00000163053, SLC16A14, solute carrier family 16 member 14, [RH, Score=207, Expect=4e-60]} {Mouse: ENSMUSG00000026220, Slc16a14, solute carrier family 16 (monocarboxylic acid transporters), member 14, [RH, Score=214, Expect=2e-62]} {Dmel: FBgn0023549, Mct1, Monocarboxylate transporter 1, [Score=186, Expect=1e-51]} {Celegans: WBGene00015676, mct-6, MonoCarboxylate Transporter family, [Score=257, Expect=3e-78]} {Smed: dd_Smed_v6_9402_0_1, dd_Smed_v6_9402_0_1, [Score=332, Expect=2e-107]} {RNA1509_37961} {RNA1310_14005} {RNA815_25187} Mlig455_033374 {REF} {Length: 3256} {Pfam: Major Facilitator Superfamily [PF07690.18, score=121.7]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=48.2]; Sugar (and other) transporter [PF00083.26, score=28.4]; Type II CAAX prenyl endopeptidase Rce1-like [PF02517.18, score=22.2]; MFS_1 like family [PF12832.9, score=20.5]; Vacuole effluxer Atg22 like [PF11700.10, score=19.2]} {Human: ENSG00000163053, SLC16A14, solute carrier family 16 member 14, [RH, Score=211, Expect=3e-61]} {Mouse: ENSMUSG00000026220, Slc16a14, solute carrier family 16 (monocarboxylic acid transporters), member 14, [RH, Score=217, Expect=1e-63]} {Dmel: FBgn0023549, Mct1, Monocarboxylate transporter 1, [Score=187, Expect=6e-52]} {Celegans: WBGene00015676, mct-6, MonoCarboxylate Transporter family, [Score=258, Expect=2e-78]} {Smed: dd_Smed_v6_9402_0_1, dd_Smed_v6_9402_0_1, [Score=334, Expect=4e-108]} {RNA1509_37961} {RNA1310_14005, RNA1509_37961} {RNA1509_37961, RNA815_25187} |
66. | MligTC455_24621 | 43 | 0.9 | Mlig455_034366 | Neo: - Age: - |
0.951 | - | - | - | - | - | 0.951 | Mlig455_034366 {REF} {Length: 575} {NoTransDecoderORF} | |
67. | MligTC455_27911 | 45 | 0.94 | Mlig455_049225, Mlig455_049228 | Neo: - |
FAT4 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_049225 {REF} {Length: 12873} {Pfam: Cadherin domain [PF00028.19, score=824.7]; Cadherin prodomain like [PF08758.13, score=35.4]; Cadherin-like [PF16184.7, score=28.6]; Peptidase propeptide and YPEB domain [PF03413.21, score=22.0]; Bacterial cadherin-like domain [PF17803.3, score=19.8]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=310, Expect=1e-83]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=368, Expect=4e-101]} {Dmel: FBgn0001075, ft, fat, [Score=283, Expect=2e-75]} {Celegans: WBGene00019994, cdh-1, CaDHerin family, [Score=176, Expect=4e-43]} {Smed: dd_Smed_v6_12895_0_1, dd_Smed_v6_12895_0_1, [Score=155, Expect=2e-37]} {RNA1509_562} {RNA1310_5} {RNA815_1} Mlig455_049228 {REF} {Length: 24107} {Pfam: Cadherin domain [PF00028.19, score=1466.0]; RET Cadherin like domain 1 [PF17756.3, score=58.7]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.5]; Cadherin-like [PF16184.7, score=34.1]; Cadherin prodomain like [PF08758.13, score=29.5]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=396, Expect=8e-109]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=389, Expect=5e-107]} {Dmel: FBgn0001075, ft, fat, [Score=334, Expect=1e-90]} {Celegans: WBGene00019994, cdh-1, CaDHerin family, [Score=183, Expect=5e-45]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [Score=158, Expect=1e-37]} {RNA1509_562} {RNA1310_5} {RNA815_1} |
68. | MligTC455_36631 | 85 | 1.78 | Mlig455_045136, Mlig455_045171 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_045136 {REF} {Length: 1192} {NoTransDecoderORF} {RNA1509_57421} {RNA1310_19938.1} {RNA815_11593} Mlig455_045171 {REF} {Length: 2421} {RNA1509_57421} {RNA1310_19938.1} {RNA815_11593} |
|
69. | MligTC455_42418 | 64 | 1.33 | Mlig455_063557 | Neo: - Age: - |
SCNN1G | 0.95 | - | - | - | - | - | 0.950 | Mlig455_063557 {REF} {Length: 3686} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=197.1]} {Human: ENSG00000166828, SCNN1G, sodium channel epithelial 1 gamma subunit, [Score=75.5, Expect=1e-13]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=53.9, Expect=4e-07]; ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=52.0, Expect=1e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=56.6, Expect=3e-08]} {Smed: dd_Smed_v6_18385_0_1, dd_Smed_v6_18385_0_1, [Score=318, Expect=6e-101]} {RNA1310_46167} {RNA815_32816} |